The Divide-Survive Matrix: decoupling proliferative drive from intrinsic survival architecture in oncology

Tumor behavior is commonly interpreted through proliferative indices and histopathological classification. However, clinical aggression and therapeutic persistence are not fully explained by proliferation alone. Lesions with comparable proliferative activity may demonstrate markedly different trajectories of progression, resistance, or metastatic potential. These discrepancies suggest that proliferative drive and baseline survival programs represent biologically distinct dimensions of tumor behavior. We introduce the Divide-Survive (DvS) Matrix as a structured two-dimensional representation integrating proliferative drive-commonly approximated by Ki-67-and intrinsic survival architecture (ISA), reflecting biological programs that support persistence independent of proliferation. Proliferative positioning may be stratified according to institutional practice or multidisciplinary consensus, including banded aggression categories, ensuring that tumor placement remains clinician-determined rather than prescriptive. ISA is conceptually distinct from therapy-induced adaptive phenomena such as metastatic drug endurance and represents baseline biological positioning at the time of diagnostic biopsy. Matrix positioning is intended as a qualitative-to-semi-quantitative interpretive exercise, guided by multidisciplinary clinical judgement rather than algorithmic assignment. By formally decoupling proliferative activity from survival architecture, the matrix offers a visual interpretive structure through which multidisciplinary teams may assess tumor aggression, clarify discordant behavior, and refine therapeutic reasoning. If prospectively evaluated, this approach may support more biologically aligned prognostic interpretation and therapeutic contextualization across histological subtypes.